Breast Neoplasms

Showing 26 - 50 of 763

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Breast Tumors Trial in Roma, Rome (Single-cell RNA sequencing (scRNAseq), whole-exome sequencing (WES))

Recruiting
  • Breast Neoplasms
  • Single-cell RNA sequencing (scRNAseq), whole-exome sequencing (WES)
  • Roma, Italy
  • +1 more
Mar 29, 2023

Breast Tumors, Breast Cancer Trial in Busan, Seoul (Breast MRI for Breast Cancer Detection)

Not yet recruiting
  • Breast Neoplasms
  • Breast Cancer
  • Breast MRI for Breast Cancer Detection
  • Busan, BusanJin-Gu, Korea, Republic of
  • +3 more
Apr 2, 2023

Breast Cancer, Breast Tumors, Surgery Trial in Jette, Genk (Patient-centered teleprehabilitation)

Recruiting
  • Breast Cancer
  • +2 more
  • Patient-centered teleprehabilitation
  • Jette, Brussels, Belgium
  • +1 more
Mar 22, 2023

Inetetamab Combined With Pyrotinib and Vinorelbine as First-line

Recruiting
  • Breast Neoplasms
  • Nanjing, Jiangsu, China
    Jiangsu Provincial People's Hospital
Mar 16, 2023

Triple Negative Breast Cancer, Breast Cancer Stage II, Breast Cancer Stage III Trial in Boston (Implantable Microdevice (IMD))

Not yet recruiting
  • Triple Negative Breast Cancer
  • +6 more
  • Implantable Microdevice (IMD)
  • Boston, Massachusetts
  • +1 more
Mar 8, 2023

DIEP Flap Surgery and Intraabdominal Pressure

Completed
  • Intraabdominal Hypertension
  • Breast Neoplasms
  • DIEP flap surgery
  • Aalborg, North Jutland, Denmark
    University hospital Aalborg
Mar 9, 2023

Breast Tumors, Chemotherapeutic Toxicity Trial in Quebec City (Application)

Recruiting
  • Breast Neoplasms
  • Chemotherapeutic Toxicity
  • Application
  • Quebec City, Quebec, Canada
    St-Sacrement Hospital
Feb 24, 2023

Breast Tumors, Breast Tumor Female, Cancer, Breast Trial in Montréal (Thoracic paravertebral block multiple (3) injections,

Recruiting
  • Breast Neoplasms
  • +3 more
  • Thoracic paravertebral block multiple (3) injections
  • Thoracic paravertebral block single injection
  • Montréal, Quebec, Canada
    CIUSSS de l'Est de l'Île de Montréal
Feb 3, 2023

Breast Cancer, Breast Tumors Trial in Fayetteville, Little Rock (Chemovax - P10s-PADRE/ MONTANIDE™ ISA 51 VG + Doxorubicin +

Completed
  • Breast Cancer
  • Breast Neoplasms
  • Chemovax - P10s-PADRE/ MONTANIDE™ ISA 51 VG + Doxorubicin + Cyclophosphamide + Docetaxel (or Paclitaxel)
  • Fayetteville, Arkansas
  • +1 more
Jan 26, 2023

Breast Mammogram and Tissue Study

Active, not recruiting
  • Breast Neoplasms
    • Burlington, Vermont
      University of Vermont
    Jan 26, 2023

    Breast Tumors Trial in Worldwide (KU-0059436 (AZD2281) (PARP inhibitor))

    Completed
    • Breast Neoplasms
    • KU-0059436 (AZD2281) (PARP inhibitor)
    • West Hollywood, California
    • +16 more
    Jan 24, 2023

    Breast Cancer, Breast Tumors, Breast Carcinoma Trial in Boston (Breast Cancer Survivor Education Program)

    Not yet recruiting
    • Breast Cancer
    • +3 more
    • Breast Cancer Survivor Education Program
    • Boston, Massachusetts
      Massachusetts General Hospital Cancer Center
    Jan 17, 2023

    Breast Tumors, Brain Tumors, Tumors by Site Trial (Abemaciclib, Elacestrant)

    Recruiting
    • Breast Neoplasms
    • +7 more
    • Canton, Ohio
      Gabrail Cancer Center
    Jan 24, 2023

    Breast Tumors Trial in Spain (No intervention)

    Recruiting
    • Breast Neoplasms
    • No intervention
    • Elche, Alicante, Spain
    • +39 more
    Jan 20, 2023

    Breast Tumors, Breast Cancer Trial in Houston, Sugar Land (Paclitaxel, Docetaxel, Abraxane)

    Completed
    • Breast Neoplasms
    • Breast Cancer
    • Houston, Texas
    • +2 more
    Jan 19, 2023

    Ovarian Tumors, Endometrial Tumors, Breast Tumors Trial in Puerto Rico, United States (PF-07260437, B7-H4 IHC)

    Recruiting
    • Ovarian Neoplasms
    • +2 more
    • Duarte, California
    • +13 more
    Jan 19, 2023

    Rehabilitation on Equal Terms - The ReMig Study

    Recruiting
    • Breast Cancer
    • Breast Neoplasms
      • Lund, Sweden
        Lund University, Skåne university hospital, Helsingborgs sjukhus
      Jan 18, 2023

      Breast Tumors Trial in Worldwide (Abemaciclib, Standard Adjuvant ET, Placebo)

      Active, not recruiting
      • Breast Neoplasms
      • Daphne, Alabama
      • +176 more
      Jan 18, 2023

      Breast Tumors, Breast Cancer, HER2-positive Early Breast Cancer Trial in Worldwide (Trastuzumab Deruxtecan, Paclitaxel,

      Recruiting
      • Breast Neoplasms
      • +2 more
      • Trastuzumab Deruxtecan
      • +5 more
      • Springdale, Arkansas
      • +203 more
      Jan 13, 2023

      Breast Tumors Trial in Padova (Personalized screening protocol)

      Active, not recruiting
      • Breast Neoplasms
      • Personalized screening protocol
      • Padova, Italy
        Istituto Oncologico Veneto (IRCCS)
      Dec 21, 2022

      HER2 Status and pCR Rate in ER-positive Breast Cancer Receiving

      Completed
      • Breast Neoplasms
      • NET or NCT
      • Haidian, Beijing, China
        Peking University Cancer Hospital
      Dec 30, 2022

      Breast Cancer Female, Breast Tumors Trial in Ghent (PET CT)

      Recruiting
      • Breast Cancer Female
      • Breast Neoplasms
      • PET CT
      • Ghent, Oost Vlaanderen, Belgium
        University Hospital Ghent
      Jan 3, 2023

      Breast Cancer: Bringing CER to the Alliance

      Completed
      • Breast Neoplasms
        • Madison, Wisconsin
          University of Wisconsin-Madison School of Medicine and Public He
        Dec 22, 2022

        Breast Tumors, Breast Diseases, Breast Fibroadenoma Trial in Chicago (Abbreviated MRI protocol: initial experience with Dotarem®

        Recruiting
        • Breast Neoplasms
        • +3 more
        • Abbreviated MRI protocol: initial experience with Dotarem® (Gadoterate Meglumine)
        • Chicago, Illinois
          University of Chicago Medicine
        Dec 21, 2022